BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33253956)

  • 1. The Use of Treatment Response Assessment Maps in Discriminating Between Radiation Effect and Persistent Tumoral Lesion in Metastatic Brain Tumors Treated with Gamma Knife Radiosurgery.
    Peker S; Samanci Y; Aygun MS; Yavuz F; Erden ME; Nokay AE; Atasoy Aİ; Bolukbasi Y
    World Neurosurg; 2021 Feb; 146():e1134-e1146. PubMed ID: 33253956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the role of delayed contrast magnetic resonance imaging (MRI) to differentiate radiation necrosis from tumour recurrence in brain metastases after stereotactic radiosurgery.
    Admojo L; Korte J; Anderson N; Phillips C; Caspersz L; Lasocki A
    J Med Imaging Radiat Oncol; 2023 Apr; 67(3):292-298. PubMed ID: 36650724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed contrast extravasation MRI: a new paradigm in neuro-oncology.
    Zach L; Guez D; Last D; Daniels D; Grober Y; Nissim O; Hoffmann C; Nass D; Talianski A; Spiegelmann R; Tsarfaty G; Salomon S; Hadani M; Kanner A; Blumenthal DT; Bukstein F; Yalon M; Zauberman J; Roth J; Shoshan Y; Fridman E; Wygoda M; Limon D; Tzuk T; Cohen ZR; Mardor Y
    Neuro Oncol; 2015 Mar; 17(3):457-65. PubMed ID: 25452395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A predictive model for distinguishing radiation necrosis from tumour progression after gamma knife radiosurgery based on radiomic features from MR images.
    Zhang Z; Yang J; Ho A; Jiang W; Logan J; Wang X; Brown PD; McGovern SL; Guha-Thakurta N; Ferguson SD; Fave X; Zhang L; Mackin D; Court LE; Li J
    Eur Radiol; 2018 Jun; 28(6):2255-2263. PubMed ID: 29178031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery.
    Mitsuya K; Nakasu Y; Horiguchi S; Harada H; Nishimura T; Bando E; Okawa H; Furukawa Y; Hirai T; Endo M
    J Neurooncol; 2010 Aug; 99(1):81-8. PubMed ID: 20058049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the radiosurgery prescription dose on the local control of small (2 cm or smaller) brain metastases.
    Mohammadi AM; Schroeder JL; Angelov L; Chao ST; Murphy ES; Yu JS; Neyman G; Jia X; Suh JH; Barnett GH; Vogelbaum MA
    J Neurosurg; 2017 Mar; 126(3):735-743. PubMed ID: 27231978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic Correlation of Cellular Imaging Using Apparent Diffusion Coefficient Quantification in Patients with Brain Metastases After Gamma Knife Radiosurgery.
    Borghei-Razavi H; Sharma M; Emch T; Krivosheya D; Lee B; Muhsen B; Prayson R; Obuchowski N; Barnett GH; Vogelbaum MA; Chao ST; Suh JH; Mohammadi AM; Angelov L
    World Neurosurg; 2020 Feb; 134():e903-e912. PubMed ID: 31733389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression?
    Belohlávek O; Simonová G; Kantorová I; Novotný J; Liscák R
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):96-100. PubMed ID: 12483415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation between Treatment-Induced Necrosis and Recurrent Tumors in Patients with Metastatic Brain Tumors: Comparison among
    Tomura N; Kokubun M; Saginoya T; Mizuno Y; Kikuchi Y
    AJNR Am J Neuroradiol; 2017 Aug; 38(8):1520-1527. PubMed ID: 28619837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishing recurrent intra-axial metastatic tumor from radiation necrosis following gamma knife radiosurgery using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
    Barajas RF; Chang JS; Sneed PK; Segal MR; McDermott MW; Cha S
    AJNR Am J Neuroradiol; 2009 Feb; 30(2):367-72. PubMed ID: 19022867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volumetric response to radiosurgery for brain metastasis varies by cell of origin.
    Iyer A; Harrison G; Kano H; Weiner GM; Luther N; Niranjan A; Flickinger JC; Lunsford LD; Kondziolka D
    J Neurosurg; 2014 Sep; 121(3):564-9. PubMed ID: 24878286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma knife radiosurgery in the treatment of patients with single and multiple brain metastases from carcinoma of the breast.
    Amendola BE; Wolf AL; Coy SR; Amendola M; Bloch L
    Cancer J; 2000; 6(2):88-92. PubMed ID: 11069225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamma Knife radiosurgery for brain metastases from pulmonary large cell neuroendocrine carcinoma: a Japanese multi-institutional cooperative study (JLGK1401).
    Kawabe T; Yamamoto M; Sato Y; Yomo S; Kondoh T; Nagano O; Serizawa T; Tsugawa T; Okamoto H; Akabane A; Aita K; Sato M; Jokura H; Kawagishi J; Shuto T; Kawai H; Moriki A; Kenai H; Iwai Y; Gondo M; Hasegawa T; Yasuda S; Kikuchi Y; Nagatomo Y; Watanabe S; Hashimoto N
    J Neurosurg; 2016 Dec; 125(Suppl 1):11-17. PubMed ID: 27903179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
    Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
    J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiotherapy: utility of intravoxel incoherent motion perfusion MRI and correlation with histopathology.
    Detsky JS; Keith J; Conklin J; Symons S; Myrehaug S; Sahgal A; Heyn CC; Soliman H
    J Neurooncol; 2017 Sep; 134(2):433-441. PubMed ID: 28674974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG PET/MRI Coregistration Helps Predict Response to Gamma Knife Radiosurgery in Patients With Brain Metastases.
    Leiva-Salinas C; Muttikkal TJE; Flors L; Puig J; Wintermark M; Patrie JT; Rehm PK; Sheehan JP; Schiff D
    AJR Am J Roentgenol; 2019 Feb; 212(2):425-430. PubMed ID: 30422717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early imaging radioresponsiveness of melanoma brain metastases as a predictor of patient prognosis.
    Zubatkina I; Ivanov P
    J Neurosurg; 2018 Aug; 129(2):354-365. PubMed ID: 28841116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma knife radiosurgery for brain metastases: do patients benefit from adjuvant external-beam radiotherapy? An 18-month comparative analysis.
    Jawahar A; Willis BK; Smith DR; Ampil F; Datta R; Nanda A
    Stereotact Funct Neurosurg; 2002; 79(3-4):262-71. PubMed ID: 12890985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible?
    Tsuyuguchi N; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Takami T; Otsuka Y; Sakamoto S; Ohata K; Goto T; Hara M
    J Neurosurg; 2003 May; 98(5):1056-64. PubMed ID: 12744366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI Treatment Response Assessment Maps (TRAMs) for differentiating recurrent glioblastoma from radiation necrosis.
    Müller SJ; Khadhraoui E; Ganslandt O; Henkes H; Gihr GA
    J Neurooncol; 2024 Feb; 166(3):513-521. PubMed ID: 38261142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.